![Ixazomib [MLN2238] Pack Size:1 mg Extracellular vesicles (EVs) are released](https://cdn.shopify.com/s/files/1/0716/2553/9802/files/ag-cr1-3670_9c732185-6a4a-4e73-b048-3c6f1a53a5f2.png?v=1753776847)
Pay in 4 interest-free payments of $53.88 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Extracellular vesicles (EVs) are released by a variety of cells into the cellular microenvironment and have the natural ability of delivering different cargos and carry bioactive molecules such as non-coding RNA
These organelles contain digestive enzymes crucial for breaking down excess or worn-out organelles
reversible
Prevents neurodegenerative processes in pathologies such as Alzheimer's and Parkinson's disease
It is associated with fibroblast differentiation by increasing α-SMA expression
Ixazomib [MLN2238] Pack Size:1 mg Extracellular vesicles (EVs) are releasedPotent selective and reversible proteasome inhibitor (all proteolytic subunits). Targets the chymotrypsin like 5 subunit of the constitutive 20S proteasome (IC50=3. 4nM). Cross reacts and inhibits the trypsin like 2 subunit (IC50=3. 5M) and the caspase like peptidyl glutamyl peptide hydrolyzing (PGPH) 1 subunit (IC50=0. 03M). Anticancer compound effective in cell based assays, in xenografts and against multiple myeloma in vivo. In vitro, induces cell
US$ 16.41
US$ 1345.00
US$ 11.15
US$ 71.00
US$ 16.90
US$ 149.50
US$ 480.50
US$ 49.00
US$ 161.50
US$ 129.00